Ipsen SA
PAR:IPN
Ipsen SA
PAR:IPN
Price:
157.7
EUR
-0.32%
Market Cap:
€13.2B
Relative Value
The Relative Value of one
IPN
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 157.7 EUR,
Ipsen SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IPN Relative Value
HIDDEN
Multiples Across Competitors
IPN Competitors Multiples
Ipsen SA Competitors
Ipsen SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Ipsen SA
PAR:IPN
|
13B EUR | 3.3 | 29.4 | 7.7 | 12.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
959.3B USD | 14.7 | 46.5 | 31.3 | 33.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.3B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
292.4B CHF | 4.8 | 31.2 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.3B GBP | 5.4 | 31.3 | 17.3 | 24.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
242.3B CHF | 5.5 | 22.3 | 13.7 | 17.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
305.1B USD | 4.7 | 16.7 | 10.4 | 12.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 3.8 | 11.5 | 8.5 | 10 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.4B USD | 2.4 | 19.5 | 7.3 | 9.7 | |
| UK |
|
GSK plc
XETRA:GS71
|
103.2B EUR | 2.7 | 15.7 | 7.9 | 11.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
